KCNH2 gene editing therapy (Trucode Gene)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameKCNH2 gene editing therapy (Trucode Gene)
Drug Alias Namepotassium voltage-gated channel subfamily H member 2 gene editing therapy (Trucode Gene)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRomano-Ward Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTrucode Gene Repair Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTrucode Gene Repair Inc
Active IndicationsN/A
Inactive IndicationsRomano-Ward Syndrome

Other Information

ATC CodeN/A
Related LinksN/A